Guidehealth Buys Arcadia’s Value-Based Care Service Division
Digital health platform company Guidehealth has acquired the managed services organization (MSO) and value-based care service division of data analytics platform company Arcadia for an undisclosed sum.
Dallas-based Guidehealth also entered into a technology agreement to leverage Boston-based Arcadia’s data analytics platform—which curates and analyzes a complex mesh of data sources to improve care delivery and financial performance—to power its newly acquired offering.
Guidehealth said it supports physicians by strengthening relationships with affiliated networks, improving financial performance of value-based risk contracts, enabling growth of high-value referrals, and reducing administrative burden. The company describes its platform as combining virtually embedded “Healthguides” and AI native workflows to bring together predictive data of a patient at the right time to maximize health outcomes and value for physicians and patients alike.
Guidehealth’s early ustomers include Endeavor Health (formerly NorthShore - Edward-Elmhurst Health) and AMITA Health Care Network.
“Guidehealth, now 200 people strong, is excited to welcome a crew who have consistently achieved Best in KLAS recognition for the past five years in value-based healthcare services as a managed services organization,” said founder and CEO Sanjay Doddamani, M.D., in a statement. “A technology partnership with Arcadia provides us with access to proven technology and deep expertise in data management that makes sense for us and partnering physicians to leap forward, reducing administrative and clinical burden to manage risk and, most importantly, to serve patients better.”
Doddamani was formerly the CEO of Upstream Health, which works to embed prescribing pharmacists and coordination nurses into primary care practices. Previously, he was chief physician executive at Southwestern Health Resources in Dallas, a senior advisor to the Center for Medicare and Medicaid Innovation (CMMI) and a chief medical officer at Geisinger.
“Arcadia is proud to have built a legacy of enhancing healthcare organizations’ abilities to improve clinical and financial outcomes,” said Arcadia President and CEO Michael Meucci, in a statement. “Partnering with Guidehealth will allow us to continue helping our customers succeed in value-based care and population health, while also empowering us to focus on our core business of providing a leading data platform for healthcare and further invest in our products that enable more complete and transparent decision making, ultimately leading to happier and healthier days for all.”
Healthcare Innovation recently interviewed Anna Basevich, senior vice president of enterprise partnerships and customer enablement at Arcadia, about the evolution of clinically integrated networks as well as the company’s work on a population health platform with the State of California to support the Cal-AIM Medicaid transformation effort.
“We have harnessed a powerful data analytics platform to manage populations across multiple regions, insurers and clinical partners to achieve better patient outcomes and reduced physician burden,” added Guidehealth Chief Technology Officer and Co-founder Michael Gleeson, in a statement. “By partnering with Arcadia, Guidehealth immediately has access to one of the best platforms for value-based care. This foundation allows us to focus on predictive and generative AI, through a combination of Guidehealth’s proprietary models and industry leading AI point solutions. As a result, we can address a number of pain points along the patient journey and helps our customers achieve predictable sustained savings in value-based care.”
Gleeson is the the former chief strategy and innovation officer at Arcadia.
Key services that Guidehealth’s newly acquired MSO currently provides include improved processes for visit access and referrals, management of prior authorizations and utilization management, network administration and paying claims to healthcare providers—especially in two-sided risk arrangements.
